Related references
Note: Only part of the references are listed.Periodic mesoporous organosilica-coated magnetite nanoparticles combined with lipiodol for transcatheter arterial chemoembolization to inhibit the progression of liver cancer
Li Liu et al.
JOURNAL OF COLLOID AND INTERFACE SCIENCE (2021)
Development and Validation of Sorafenib-eluting Microspheres to Enhance Therapeutic Efficacy of Transcatheter Arterial Chemoembolization in a Rat Model of Hepatocellular Carcinoma
Wooram Park et al.
RADIOLOGY-IMAGING CANCER (2021)
Neutralization of CXCL12 attenuates established pulmonary hypertension in rats
Jennifer Bordenave et al.
CARDIOVASCULAR RESEARCH (2020)
Idarubicin vs doxorubicin in transarterial chemoembolization of intermediate stage hepatocellular carcinoma
Gael Stephane Roth et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2020)
Co-targeting of CXCR4 and hedgehog pathways disrupts tumor-stromal crosstalk and improves chemotherapeutic efficacy in pancreatic cancer
Mohammad Aslam Khan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
SOX4 activates CXCL12 in hepatocellular carcinoma cells to modulate endothelial cell migration and angiogenesis in vivo
Chi-Neu Tsai et al.
ONCOGENE (2020)
CXCR4 antagonist AMD3100 (plerixafor): From an impurity to a therapeutic agent
Jingzhe Wang et al.
PHARMACOLOGICAL RESEARCH (2020)
Recent Updates of Transarterial Chemoembolilzation in Hepatocellular Carcinoma
Young Chang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Angiogenesis and immune checkpoint inhibitors as therapies for hepatocellular carcinoma: current knowledge and future research directions
Marc Hilmi et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Updated use of TACE for hepatocellular carcinoma treatment: How and when to use it based on clinical evidence
Jean-Luc Raoul et al.
CANCER TREATMENT REVIEWS (2019)
The Role of Angiogenesis in Hepatocellular Carcinoma
Michael A. Morse et al.
CLINICAL CANCER RESEARCH (2019)
Chemokines and Chemokine Receptors: New Targets for Cancer Immunotherapy
Valeria Mollica Poeta et al.
FRONTIERS IN IMMUNOLOGY (2019)
MiR-744-5p inducing cell death by directly targeting HNRNPC and NFIX in ovarian cancer cells
Michael Kleemann et al.
SCIENTIFIC REPORTS (2018)
Plerixafor Improves Primary Tumor Response and Reduces Metastases in Cervical Cancer Treated with Radio-Chemotherapy
Naz Chaudary et al.
CLINICAL CANCER RESEARCH (2017)
Targeting the CXCR4/CXCL12 axis in treating epithelial ovarian cancer
T. L. Mao et al.
GENE THERAPY (2017)
Mechanisms of Regulation of the Chemokine-Receptor Network
Martin J. Stone et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment
Meili Wang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
Angiogenic Capacity of Dental Pulp Stem Cell Regulated by SDF-1α-CXCR4 Axis
Hyun Nam et al.
STEM CELLS INTERNATIONAL (2017)
Stromal cell-derived factor-1 (SDF-1) as a target in liver diseases
Anke Liepelt et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2016)
Effectiveness of AMD3100 in treatment of leukemia and solid tumors: from original discovery to use in current clinical practice
Tao Liu et al.
EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2016)
CXCR4-targeted lipid-coated PLGA nanoparticles deliver sorafenib and overcome acquired drug resistance in liver cancer
Dong-Yu Gao et al.
BIOMATERIALS (2015)
CXCR4 Inhibition in Tumor Microenvironment Facilitates Anti-Programmed Death Receptor-1 Immunotherapy in Sorafenib-Treated Hepatocellular Carcinoma in Mice
Yunching Chen et al.
HEPATOLOGY (2015)
A preclinical orthotopic model for glioblastoma recapitulates key features of human tumors and demonstrates sensitivity to a combination of MEK and PI3K pathway inhibitors
Rajaa El Meskini et al.
DISEASE MODELS & MECHANISMS (2015)
Effect of a nitric oxide synthase inhibitor and a CXC chemokine receptor-4 antagonist on tumor growth and metastasis in a xenotransplanted mouse model of adenoid cystic carcinoma of the oral floor
Kazuki Takaoka et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
CXCR4-Targeted Therapy Inhibits VEGF Expression and Chondrosarcoma Angiogenesis and Metastasis
Xiaojuan Sun et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Post-TACE Combination Therapy of Heparin and Octreotide Results in Decreased Tumor Metastasis in Extrahepatic Tumorigenesis
Weidong Jia et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2012)
CXCR4 Inhibitors: Tumor Vasculature and Therapeutic Challenges
Filomena de Nigris et al.
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY (2012)
Chemokine receptor CXCR4 expression in hepatocellular carcinoma patients increases the risk of bone metastases and poor survival
Zuo-lin Xiang et al.
BMC CANCER (2009)
Drug-loaded microspheres for the treatment of liver cancer: Review of current results
Joachim Kettenbach et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2008)
Roles of Chemokine Receptor 4 (CXCR4) and Chemokine Ligand 12 (CXCL12) in Metastasis of Hepatocellular Carcinoma Cells
Hui Liu et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2008)
Share Paper
